# Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)

> **NCT01546116** · PHASE4 · COMPLETED · sponsor: **Korea University** · enrollment: 20 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** ADEFOVIR, LAMIVUDINE

## Key facts

- **NCT ID:** NCT01546116
- **Lead sponsor:** Korea University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2012-02
- **Final completion:** 2014-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01546116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01546116, "Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01546116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*